𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of circulating tumor necrosis factor-α in patients with gynecological malignancies

✍ Scribed by Dr. Pierandrea De Jaco; Bernard Asselain; Camillo Orlandi; Wolf Herman Fridman; Dr. Jean-Luc Teillaud

Publisher
John Wiley and Sons
Year
1991
Tongue
French
Weight
513 KB
Volume
48
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

TNF‐α levels in sera from patients with gynecological cancers were evaluated by ELISA and compared with those of patients with benign ovarian cysts or of anonymous healthy donors. Patients with cervical and endometrial carcinoma and with benign ovarian cysts showed levels of TNF‐α similar to those of healthy donors. In contrast, significantly increased levels of TNF‐α were found in patients with ovarian carcinoma, regardless of the stage of disease.

📜 SIMILAR VOLUMES

Increased risk of coccidioidomycosis in
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
✍ Laurie Bergstrom; David E. Yocum; Neil M. Ampel; Isidro Villanueva; Jeffrey Liss 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Objective To describe a group of patients who were treated with tumor necrosis factor α (TNFα) antagonists and who developed coccidioidomycosis, and to test the hypothesis that patients with inflammatory arthritis receiving TNFα antagonist therapy are at higher risk for developing s

Circulating levels of tumor necrosis fac
Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis
✍ Derek L. Mattey; John R. Glossop; Nicola B. Nixon; Peter T. Dawes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Abstract ## Objective To investigate whether circulating levels of soluble tumor necrosis factor receptors (sTNFR) are predictive of mortality in rheumatoid arthritis (RA). ## Methods Levels of sTNFRI and sTNFRII at study entry were quantified using enzyme‐linked immunosorbent assays in sera